Key facts
- This page summarizes Robert Benjamin Stein's Form 4 filing for MIMEDX GROUP, INC. (MDXG).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 30 Jun 2022, 19:09.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Additional SEC filing notes
Footnote F1
The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $3.47 to $3.48, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.